CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 13,488	$ 15,887
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	12,756	1,912
Impairment of goodwill	0	8,404
Loss on impairment of intangible assets	5,771	0
Right-of-use amortization and cease use costs	415	333
Amortization of debt issuance costs	1,054	493
Deferred income taxes, net	4,807	(1,286)
Unrealized net (gain) loss on warrants	(2,406)	55
Net (gain) loss on exercise and cancellation of warrants	(445)	799
Net loss on marketable investments	266	0
Change in fair value of acquisition-related contingent consideration	(4,900)	(6,300)
Gain on revaluation of finance receivable	(2,495)	0
Foreign currency transaction gain	(1,414)	(1,876)
Loan discount amortization and fee accretion	(3,918)	(3,827)
Interest paid-in-kind	(2,807)	(1,826)
Stock-based compensation	944	509
Depreciation and amortization expense	1,399	2,577
Changes in operating assets and liabilities:
Interest, accounts receivable and other receivables, net	(1,059)	(1,635)
Derivative assets and liabilities, net	1,229	1,059
Other assets	199	(787)
Accounts payable, accrued expenses, and other non-current liabilities	(1,326)	371
Deferred income	1,491	26
Net cash provided by operating activities	23,049	14,888
Cash flows from investing activities:
Sale of finance receivables	0	13,942
Sale of marketable investments	574	0
Investment in finance receivables	(63,706)	(74,125)
Repayment of finance receivables	53,109	11,703
Corporate debt securities principal payments	27	28
Purchases of property and equipment	(138)	(496)
Net cash used in investing activities	(10,134)	(48,948)
Cash flows from financing activities:
Net settlement for employee taxes on stock options	(43)	0
Net (payments on) proceeds from credit facility	(6,117)	9,905
Payments for financing costs	(50)	(3,407)
Proceeds from senior unsecured notes	0	32,969
Repurchases of common stock, including fees and expenses	(6,014)	(6,327)
Net cash (used in) provided by financing activities	(12,224)	33,140
Net increase (decrease) in cash, cash equivalents, and restricted cash	691	(920)
Cash, cash equivalents, and restricted cash at beginning of period	5,236	6,156
Cash, cash equivalents, and restricted cash at end of period	5,927	5,236
Supplemental non-cash investing and financing activities:
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	82	0
Cash paid for interest	3,082	1,351
Fair value of warrants received with finance receivables	$ 1,241	$ 1,364